These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 35366762

  • 1. Ruthenium Metallotherapeutics: Novel Approaches to Combatting Parasitic Infections.
    Britten NS, Butler JA.
    Curr Med Chem; 2022 Aug 15; 29(31):5159-5178. PubMed ID: 35366762
    [Abstract] [Full Text] [Related]

  • 2. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.
    Sánchez-Delgado RA, Anzellotti A.
    Mini Rev Med Chem; 2004 Jan 15; 4(1):23-30. PubMed ID: 14754440
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vanadium compounds as antiparasitic agents: An approach to their mechanisms of action.
    Brenda CT, Norma RF, Marcela RL, Nelly LV, Teresa F.
    J Trace Elem Med Biol; 2023 Jul 15; 78():127201. PubMed ID: 37210920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis.
    Francesconi V, Rizzo M, Schenone S, Carbone A, Tonelli M.
    Curr Med Chem; 2024 Jul 15; 31(15):1955-1982. PubMed ID: 37718524
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Host-directed therapies for parasitic diseases.
    Singh B, Varikuti S, Halsey G, Volpedo G, Hamza OM, Satoskar AR.
    Future Med Chem; 2019 Aug 15; 11(15):1999-2018. PubMed ID: 31390889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents.
    Ribeiro R, Costa L, Pinto E, Sousa E, Fernandes C.
    Mar Drugs; 2023 Nov 25; 21(12):. PubMed ID: 38132930
    [Abstract] [Full Text] [Related]

  • 13. Potential chemotherapeutic targets in the purine metabolism of parasites.
    el Kouni MH.
    Pharmacol Ther; 2003 Sep 25; 99(3):283-309. PubMed ID: 12951162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases.
    Zucca M, Scutera S, Savoia D.
    Curr Med Chem; 2013 Sep 25; 20(4):502-26. PubMed ID: 23210775
    [Abstract] [Full Text] [Related]

  • 16. Anti-parasitic Antibodies from Phage Display.
    Goulart LR, da S Ribeiro V, Costa-Cruz JM.
    Adv Exp Med Biol; 2017 Sep 25; 1053():155-171. PubMed ID: 29549639
    [Abstract] [Full Text] [Related]

  • 17. Heme metabolism as a therapeutic target against protozoan parasites.
    Lechuga GC, Pereira MCS, Bourguignon SC.
    J Drug Target; 2019 Aug 25; 27(7):767-779. PubMed ID: 30332897
    [Abstract] [Full Text] [Related]

  • 18. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.
    Date AA, Joshi MD, Patravale VB.
    Adv Drug Deliv Rev; 2007 Jul 10; 59(6):505-21. PubMed ID: 17574295
    [Abstract] [Full Text] [Related]

  • 19. HDAC inhibitors in parasitic diseases.
    Andrews KT, Haque A, Jones MK.
    Immunol Cell Biol; 2012 Jan 10; 90(1):66-77. PubMed ID: 22124373
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance.
    Sadr S, Ahmadi Simab P, Niazi M, Yousefsani Z, Lotfalizadeh N, Hajjafari A, Borji H.
    Expert Rev Anti Infect Ther; 2024 Jun 10; 22(6):435-451. PubMed ID: 38804866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.